A prospective study of thyroid profile in children aged 1 month to 12 years of age with newly diagnosed seizure disorder started on first line antiepileptic drugs
DOI:
https://doi.org/10.18203/2349-3291.ijcp20230419Keywords:
Antiepileptic drugs, Hypothyroidism, Thyroid profile, SeizuresAbstract
Background: The study's primary aim was to determine the variation in the thyroid profile status in children with newly diagnosed seizure disorders started on first-line antiepileptic drugs. In addition, this study compares the incidence of hypothyroidism secondary to phenytoin, phenobarbitone, valproate and carbamazepine.
Methods: A total of 60 children with newly diagnosed seizure disorders belonging to the age group of 1 month to 12 years were enrolled in the study. The children were subjected to a detailed history and neurological examination, and serum levels of T3, T4, and thyroid-stimulating hormone (TSH) were tested.
Results: In this study, out of 60 children, the clinical signs and symptoms of hypothyroidism were present only in one subject (1.7%), and the remaining 59 had no signs and symptoms of hypothyroidism. The mean TSH value increased from baseline 1.62±1.17 to 3 months 2.2±1.38 and 6 months 2.78±149 (p value<0.05%). The incidence of subclinical hypothyroidism among the phenytoin group (n=33) was 6.06%. Among the sodium valproate group (n=23), the incidence was 8.6%, and among the carbamazepine group (n=4), the incidence was 25%.
Conclusions: Antiepileptic drugs can alter thyroid function tests. In this study, there was no overt hypothyroidism noted. But subclinical hypothyroidism was reported in subjects using phenytoin, valproate and carbamazepine.
References
Fisher RS, Boas W van E, Blume W, Elger C, Genton P, Lee P, et al. Epileptic Seizures and Epilepsy: Definitions Proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005;46(4):470-2.
Fatigue in multiple sclerosis – Insights into evaluation and management - ScienceDirect. Available at: https://www.sciencedirect.com/ science/article/abs/pii/S0987705316303847. Accessed on 11 January 2023.
Hoermann R, Midgley JEM, Larisch R, Dietrich JW. Homeostatic Control of the Thyroid–Pituitary Axis: Perspectives for Diagnosis and Treatment. Front Endocrinol. 2015;6.
Yilmaz B, Terekeci H, Sandal S, Kelestimur F. Endocrine disrupting chemicals: exposure, effects on human health, mechanism of action, models for testing and strategies for prevention. Rev Endocr Metab Disord. 2020;21(1):127-47.
Yokoyama S, Tanaka Y, Hosomi K, Takada M. Polypharmacy Is Associated With Amiodarone-Induced Hypothyroidism. Int J Med Sci. 2021;18(15):3574-80.
Verrotti A, Scardapane A, Manco R, Chiarelli F. Anti-epileptic Drugs and Thyroid Function. J Pediatric Endocrinol Metab. 2008;21:401-8.
Dhodi DK, Bhagat SB, Patil KC. A comparative study of thyroid status of patients on phenytoin, carbamazepine and valproate monotherapy. Int J Basic Clin Pharmacol. 2016;5(2):362-5.
Thienpont LM, Uytfanghe KV, De Grande LAC, Reynders D, Das B, Faix JD. Harmonization of Serum Thyroid-Stimulating Hormone Measurements Paves the Way for the Adoption of a More Uniform Reference Interval. Clin Chem. 2017;63(7):1248-60.
Kim SH, Chung HR, Kim SH, Kim H, Lim BC, Chae JH. Subclinical Hypothyroidism during Valproic Acid Therapy in Children and Adolescents with Epilepsy. Neuropediatrics. 2012;43(03):135-9.
Yılmaz U, Yılmaz TS, Akıncı G, Korkmaz HA, Tekgül H. The effect of anti-epileptic drugs on thyroid function in children. Seizure. 2014;23(1):29-35.
